Enbrel “Black Box” Under Consideration By FDA, Amgen Execs Say

Amgen also has received two federal subpoenas related to its products, the firm discloses.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet